CPG Sec. 635.100 Large Volume Parenterals (LVPs) for Animal Use

Issue Date: March 1, 2019
Issued by: Center for Veterinary Medicine
Topic(s): Investigation & Enforcement, Animal Drugs
Status: Final

CPG Sec. 635.100 Large Volume Parenterals (LVPs) for Animal Use

The purpose of this compliance policy guide (CPG) is to provide guidance for FDA staff on large volume parenterals (LVPs or large volume injections).

Download the Guidance Document

webmaster2026-08-05T19:03:08+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.